IL1B and lymphoma: As for another NLRP3 effector molecule, though plasma IL-1β level in newly-diagnosed lymphoma patients was significantly higher than in controls (p = 0.0031, Figure 2F), no significant decrease was found after chemotherapy remission (p = 0.1015, Figure 2G).